202 related articles for article (PubMed ID: 9496231)
1. Characterisation of the biological effects of neurohypophysial peptides on seminiferous tubules.
Harris GC; Nicholson HD
J Endocrinol; 1998 Jan; 156(1):35-42. PubMed ID: 9496231
[TBL] [Abstract][Full Text] [Related]
2. Stage-related differences in rat seminiferous tubule contractility in vitro and their response to oxytocin.
Harris GC; Nicholson HD
J Endocrinol; 1998 May; 157(2):251-7. PubMed ID: 9659288
[TBL] [Abstract][Full Text] [Related]
3. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
Ingram CD; Tolchard S
J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
[TBL] [Abstract][Full Text] [Related]
4. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
5. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
[TBL] [Abstract][Full Text] [Related]
6. Design of oxytocin antagonists, which are more selective than atosiban.
Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
[TBL] [Abstract][Full Text] [Related]
7. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
[TBL] [Abstract][Full Text] [Related]
8. Characterization and localization of oxytocin receptors in the rat testis.
Bathgate RA; Sernia C
J Endocrinol; 1994 May; 141(2):343-52. PubMed ID: 8046305
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
[TBL] [Abstract][Full Text] [Related]
10. Rat testicular myoid cells express vasopressin receptors: receptor structure, signal transduction, and developmental regulation.
Howl J; Rudge SA; Lavis RA; Davies AR; Parslow RA; Hughes PJ; Kirk CJ; Michell RH; Wheatley M
Endocrinology; 1995 May; 136(5):2206-13. PubMed ID: 7536665
[TBL] [Abstract][Full Text] [Related]
11. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
Akerlund M; Melin P; Maggi M
Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban.
Manning M; Miteva K; Pancheva S; Stoev S; Wo NC; Chan WY
Int J Pept Protein Res; 1995; 46(3-4):244-52. PubMed ID: 8537178
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin receptor subtypes in the pregnant rat myometrium and decidua: pharmacological differentiations.
Chan WY; Chen DL; Manning M
Endocrinology; 1993 Mar; 132(3):1381-6. PubMed ID: 8382600
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.
Maggi M; Malozowski S; Kassis S; Guardabasso V; Rodbard D
Endocrinology; 1987 Mar; 120(3):986-94. PubMed ID: 3026794
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens.
Robinzon B; Koike TI; Marks PA
Peptides; 1994; 15(8):1407-13. PubMed ID: 7700844
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
Poulin P; Pittman QJ
J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
Soloff MS; Fernström MA; Fernström MJ
Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
[TBL] [Abstract][Full Text] [Related]
19. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
[TBL] [Abstract][Full Text] [Related]
20. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
Chan WY; Wo NC; Cheng LL; Manning M
J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
